Immunosuppression by phenytoin

Implication for altered immune competence in brain-tumor patients

K. Kikuchi, C. I. McCormick, Edward Neuwelt

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

This investigation was conducted to examine the immunosuppressive potential of phenytoin in vivo and to document a correlation between phenytoin therapy and depressed lymphocyte responsiveness to mitogens. It was thought that phenytoin, the most widely used anticonvulsant agent, may play some role in the immunosuppression seen in brain-tumor patients. The effect of phenytoin on mitogen-stimulated lymphocyte function was evaluated by tritiated (3H)-thymidine incorporation and lymphocyte nuclear size distribution. Lymphocytes from either phenytoin-treated or normal rabbits were incubated for 90 hours in culture medium in the presence of 3 mitogens: phytohemagglutinin (PHA), concanavalin A (Con A), and pokeweed mitogen (PWM). Significant suppression of mitogen-induced activation of the lymphocytes from treated animals was demonstrated. The present studies suggest a possible connection beween phenytoin therapy and altered immune competence in brain-tumor patients.

Original languageEnglish (US)
Pages (from-to)1085-1090
Number of pages6
JournalJournal of Neurosurgery
Volume61
Issue number6
StatePublished - 1984

Fingerprint

Phenytoin
Brain Neoplasms
Mental Competency
Immunosuppression
Mitogens
Lymphocytes
Pokeweed Mitogens
Phytohemagglutinins
Immunosuppressive Agents
Lymphocyte Activation
Concanavalin A
Anticonvulsants
Thymidine
Culture Media
Rabbits
Therapeutics

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)

Cite this

Immunosuppression by phenytoin : Implication for altered immune competence in brain-tumor patients. / Kikuchi, K.; McCormick, C. I.; Neuwelt, Edward.

In: Journal of Neurosurgery, Vol. 61, No. 6, 1984, p. 1085-1090.

Research output: Contribution to journalArticle

@article{58df5aa5595348d8bc42d6547c817272,
title = "Immunosuppression by phenytoin: Implication for altered immune competence in brain-tumor patients",
abstract = "This investigation was conducted to examine the immunosuppressive potential of phenytoin in vivo and to document a correlation between phenytoin therapy and depressed lymphocyte responsiveness to mitogens. It was thought that phenytoin, the most widely used anticonvulsant agent, may play some role in the immunosuppression seen in brain-tumor patients. The effect of phenytoin on mitogen-stimulated lymphocyte function was evaluated by tritiated (3H)-thymidine incorporation and lymphocyte nuclear size distribution. Lymphocytes from either phenytoin-treated or normal rabbits were incubated for 90 hours in culture medium in the presence of 3 mitogens: phytohemagglutinin (PHA), concanavalin A (Con A), and pokeweed mitogen (PWM). Significant suppression of mitogen-induced activation of the lymphocytes from treated animals was demonstrated. The present studies suggest a possible connection beween phenytoin therapy and altered immune competence in brain-tumor patients.",
author = "K. Kikuchi and McCormick, {C. I.} and Edward Neuwelt",
year = "1984",
language = "English (US)",
volume = "61",
pages = "1085--1090",
journal = "Journal of Neurosurgery",
issn = "0022-3085",
publisher = "American Association of Neurological Surgeons",
number = "6",

}

TY - JOUR

T1 - Immunosuppression by phenytoin

T2 - Implication for altered immune competence in brain-tumor patients

AU - Kikuchi, K.

AU - McCormick, C. I.

AU - Neuwelt, Edward

PY - 1984

Y1 - 1984

N2 - This investigation was conducted to examine the immunosuppressive potential of phenytoin in vivo and to document a correlation between phenytoin therapy and depressed lymphocyte responsiveness to mitogens. It was thought that phenytoin, the most widely used anticonvulsant agent, may play some role in the immunosuppression seen in brain-tumor patients. The effect of phenytoin on mitogen-stimulated lymphocyte function was evaluated by tritiated (3H)-thymidine incorporation and lymphocyte nuclear size distribution. Lymphocytes from either phenytoin-treated or normal rabbits were incubated for 90 hours in culture medium in the presence of 3 mitogens: phytohemagglutinin (PHA), concanavalin A (Con A), and pokeweed mitogen (PWM). Significant suppression of mitogen-induced activation of the lymphocytes from treated animals was demonstrated. The present studies suggest a possible connection beween phenytoin therapy and altered immune competence in brain-tumor patients.

AB - This investigation was conducted to examine the immunosuppressive potential of phenytoin in vivo and to document a correlation between phenytoin therapy and depressed lymphocyte responsiveness to mitogens. It was thought that phenytoin, the most widely used anticonvulsant agent, may play some role in the immunosuppression seen in brain-tumor patients. The effect of phenytoin on mitogen-stimulated lymphocyte function was evaluated by tritiated (3H)-thymidine incorporation and lymphocyte nuclear size distribution. Lymphocytes from either phenytoin-treated or normal rabbits were incubated for 90 hours in culture medium in the presence of 3 mitogens: phytohemagglutinin (PHA), concanavalin A (Con A), and pokeweed mitogen (PWM). Significant suppression of mitogen-induced activation of the lymphocytes from treated animals was demonstrated. The present studies suggest a possible connection beween phenytoin therapy and altered immune competence in brain-tumor patients.

UR - http://www.scopus.com/inward/record.url?scp=0021716897&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021716897&partnerID=8YFLogxK

M3 - Article

VL - 61

SP - 1085

EP - 1090

JO - Journal of Neurosurgery

JF - Journal of Neurosurgery

SN - 0022-3085

IS - 6

ER -